Home / Articles / Access to 1,2,4-triazole-tethered potential CRBN ligands starting from α-diazo glutarimide and azlactones
JUST ACCEPTED ARTICLE. This article has been peer-reviewed and accepted for publication. It is citable and carries a permanent DOI. This version has not been copyedited or typeset and will be replaced by the final version of record.

Access to 1,2,4-triazole-tethered potential CRBN ligands starting from α-diazo glutarimide and azlactones

R. A. Kuznetsov 1, 
R. A. Kuznetsov
G. P. Kantin 1, 
G. P. Kantin
A. S. Bunev 2, 
A. S. Bunev
D. V. Dar'in 1*
D. V. Dar'in
Published 15 October 2026 , received 11 June 2026
Communication
0
Cite this
GOST
 | 
Cite this
GOST
Kuznetsov R. A. et al. Access to 1,2,4-triazole-tethered potential CRBN ligands starting from α-diazo glutarimide and azlactones // Mendeleev Communications. 2026.
GOST all authors (up to 50)
Kuznetsov R. A., Kantin G. P., Bunev A. S., Dar'in D. V. Access to 1,2,4-triazole-tethered potential CRBN ligands starting from α-diazo glutarimide and azlactones // Mendeleev Communications. 2026.
RIS
 | 
Cite this
RIS
TY - JOUR
DO - 10.71267/mencom.8116
UR - https://mendcomm.colab.ws/publications/10.71267/mencom.8116
TI - Access to 1,2,4-triazole-tethered potential CRBN ligands starting from α-diazo glutarimide and azlactones
T2 - Mendeleev Communications
AU - Kuznetsov, R. A.
AU - Kantin, G. P.
AU - Bunev, A. S.
AU - Dar'in, D. V.
PY - 2026
DA - 2026/10/15
PB - Mendeleev Communications
ER -
BibTex
Cite this
BibTex (up to 50 authors)
@article{2026_Kuznetsov,
author = {R. A. Kuznetsov and G. P. Kantin and A. S. Bunev and D. V. Dar'in},
title = {Access to 1,2,4-triazole-tethered potential CRBN ligands starting from α-diazo glutarimide and azlactones},
journal = {Mendeleev Communications},
year = {2026},
publisher = {Mendeleev Communications},
month = {Oct},
url = {https://mendcomm.colab.ws/publications/10.71267/mencom.8116},
doi = {10.71267/mencom.8116}
}
Views
42

Abstract

A method was developed for the preparation of hitherto unknown 1,2,4-triazol-1-yl-substituted glutarimide derivatives, based on the reaction of an α-diazo glutarimide reagent with azlactones generated in situ from N-acyl-α-amino acids. This base-catalyzed cyclocondensation provides good-to-high yields of the triazole-glutarimide dyads under mild conditions and allows for broad variation of substituents at both positions of the triazole ring. Following deprotection of the imide NH group, evaluation of the cytotoxicity of the resulting glutarimides against human multiple myeloma cells and peripheral blood mononuclear cells showed no significant effect on viability, indicating a favorable safety profile compared to known cereblon (CRBN) ligands of the immunomodulatory imide drug (IMiD) class.

Keywords

1,2,4-trizoles
azlactones
CRBN ligands
diazo compounds
glutarimide